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W
ith this volume, Emerging Infectious Diseases (EID)
turns 10—a time probably between childhood and
adolescence in journal years. All of us associated with the
journal are very proud of this milestone, but at the same
time we are aware of the need to continually assess
progress toward original goals and make changes when
and where needed.
EID’s genesis stems from advice to the Centers for
Disease Control and Prevention (CDC) promulgated by
the 1992 Institute of Medicine report, Emerging
Infections: Microbial Threats to Health in the United
States (1). EID was envisaged as a vital component of
CDC’s effort to communicate the threat of emerging infec-
tions worldwide. Fully and for the most part externally
peer reviewed, the journal would have an international edi-
torial board and would seek a global readership base. Its
broad-based content would mirror the complex microbial,
demographic, genetic, economic, technologic, behavioral,
social, and other factors (including nefarious ones) that
contribute to infectious disease emergence. The format
would include views and summaries of major disease top-
ics and trends, reports of new agents, reservoirs or foci of
infection, and timely or preliminary results of relevant
research. To make possible swift global dissemination of
this compelling content, the journal would be fully elec-
tronic and be distributed free of charge, a concept being
robustly discussed in 2005 by many editors and publishers
under the topic of “open access.” Special features were
soon added to emphasize the links between science, public
health, and the human condition.  
If submissions and subscriptions are a measure of read-
er interest, Emerging Infectious Diseases has enjoyed
some success during its first decade. Readership (infec-
tious disease professionals in academia, clinical practice,
industry, public health, and related disciplines) has grown
from 3,000 subscribers in 1995 to >45,000 (print and
online, >6,000 international). Submissions are increasing
and number >120 per month. Although most submissions
come from scientists in the United States and western
Europe, manuscripts continue to arrive in substantial and
increasing numbers from every part of the globe. The jour-
nal, which is widely indexed, has a consistently high
impact factor (fourth most cited of 41 infectious disease
journals, Institute of Scientific Information citation
reports, 2003).
Electronic publishing, the dynamic concept driving
Emerging Infectious Diseases, has made huge strides dur-
ing the journal’s first decade. Ahead-of-print publication, a
founding feature of Emerging Infectious Diseases, is now
common practice in the scientific journal community.
Online-only publication of technical and lengthy but valu-
able parts of articles has also been adopted by many jour-
nals. Multiple links to references, databases, and other
relevant information have become standard. Interactive
features and instant access to authors and editors have rev-
olutionized scientific dialog. EID’s impulse to swiftly pro-
vide urgent information free of charge to a global audience
has been reaffirmed by several recent movements toward
free access to scientific data.
During its 10-year journey, Emerging Infectious
Diseases has had some advantages. Providing unrestricted
access to all content has allowed the journal to reach its
intended audience of public health professionals around
the globe. In-house production has made possible timely
posting of articles on the Web as soon as they are cleared
for publication. A small but uniquely competent and flexi-
ble production team, dedicated associate editors and edito-
rial board, and thousands of volunteer expert reviewers
have energized our journal’s growing contribution to the
public health community.
Like all anniversaries, our journal’s 10th is a combina-
tion of reflecting on the past and looking into the future.
From the public health perspective, the world’s current sit-
uation is every bit as volatile as it was 10 years ago, perhaps
even more so. New infectious diseases and etiologic agents
(e.g., avian influenza, Nipah virus infection, SARS) contin-
ue to surface relentlessly. Other diseases are finding new
niches. West Nile virus encephalitis, endemic to the Eastern
Hemisphere, became established in the northeastern United
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dicted within the public health community, multidrug-
resistant bacterial infections have become increasingly
commonplace, yet development of new antimicrobial
drugs has failed to keep pace. Against this backdrop of nat-
urally occurring problems, intentional release of pathogen-
ic organisms has surfaced as a threat to public health and
global security. The Institute of Medicine revisited the
issue they brought to the world’s attention in 1992 with
another report in 2003 (2). Their advice is not dissimilar to
that of the Red Queen to Lewis Carroll’s Alice in
Wonderland: “…it takes all the running you can do, to
keep in the same place. If you want to get somewhere else,
you must run at least twice as fast as that!” (3).
From the journal publishing perspective, continued
emergence of new diseases and agents compels rapid dis-
semination of relevant scientific and public health infor-
mation on the Web. As electronic access has become more
commonplace, Web audiences have increased, and while
in 1995 we had to educate readers on how to access our
electronic journal, now we strive to keep up with their
increased sophistication and need for additional research
tools. In the ever-changing world of electronic publishing,
speed is no longer the greatest challenge. Traditional pub-
lishing bottlenecks are diminishing. Web-based submis-
sion and peer review shrink the time from manuscript
submission to publication. Online editing and production
have advanced to the benefit of the final product. The
question is no longer how fast information can be pub-
lished but how content quality can keep up with technolog-
ic speed (4). When anthrax spores were disseminated
through the U.S. postal system, Emerging Infectious
Diseases published online a peer-reviewed article describ-
ing the first 10 cases. This definitive article (5), published
online 5 days after submission, provided healthcare profes-
sionals the information needed to recognize potential new
cases. When SARS burst onto the public health scene,
Emerging Infectious Diseases published an entire issue
with >40 peer-reviewed articles on a disease that 12
months earlier was not known to exist (see
http://www.cdc.gov/ncidod/EID/vol10no2/contents_
v10n2.htm). The technology that allowed these and other
cases of expedited publication continues to advance.
However, the ability to collect and interpret data on
unknown diseases and uncharacterized agents follows a
different timetable, in which quality must continue to take
precedence over speed.
Electronic publishing provides solutions and poses
challenges. Online-only publication for selected sections
of journal materials may, in the short term, ease space con-
straints that threaten the journal’s ability to remain inclu-
sive. Expansive indexing will further refine electronic
search capabilities, increase links to large electronic data-
bases, and improve the pace and quality of emerging infec-
tions and other research. The breadth and complexity of
online activities will continue to demand increased techni-
cal expertise and exceptional flexibility from all involved
with the journal—authors, reviewers, editors, and produc-
tion staff.
As Emerging Infectious Diseases begins its second
decade, its primary goal remains to communicate the threat
of emerging infections worldwide and reduce the global
impact of these infections, particularly among the young,
the old, and the immunocompromised. The principal dif-
ference between 1995 and now is the pace, both of current
events and of expected publication. Our challenge for the
coming decade is not only to keep up with an increasing
pace, but also to set the pace whenever we can, or in the
words of one track coach, “Start off as fast as you can, and
then gradually pick up speed.”
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